Windlas Biotech Ltd (WINDLAS) Financials - Quarterly Results, Profit & Loss, Balance Sheet, Cash Flow Windlas Biotech Ltd reported sales of ₹238 Cr, operating profit of ₹25 Cr (OPM 11%) and net profit of ₹16 Cr for the quarter ended Mar 2026. Figures in ₹ crore, consolidated where available.
WINDLAS quarterly results (₹ Cr) Metric Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Sales 175 187 195 203 210 222 233 238 Expenses 154 164 170 177 184 194 209 213 Operating Profit 21 23 25 26 27 29 24 25 OPM 12% 12% 13% 13% 13% 13% 10% 11% Other Income 4 5 4 5 5 4 5 4 Interest 0 1 1 1 1 1 1 1 Depreciation 6 6 7 8 7 8 8 8 Profit before tax 18 20 20 21 23 24 20 20 Tax 26% 23% 23% 22% 24% 25% 25% 21% Net Profit 13 16 16 16 18 18 15 16 EPS in Rs 6.45 7.49 7.45 7.77 8.43 8.45 7.12 7.58
WINDLAS profit & loss, annual (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM Sales 466 513 631 760 904 868 Expenses 414 453 553 666 799 763 Operating Profit 52 60 78 94 105 105 OPM 11% 12% 12% 12% 12% 12% Other Income 7 10 13 18 18 18 Interest 1 1 1 4 5 5 Depreciation 12 12 13 28 31 31 Profit before tax 46 57 77 80 87 88 Tax 16% 25% 25% 24% 24% - Net Profit 38 43 58 61 66 67 EPS in Rs 17.48 20.04 27.98 29.1 31.49 31.77 Dividend Payout 20% 20% 20% 20% 20% -
WINDLAS balance sheet (₹ Cr) Metric Mar 2023 Mar 2024 Mar 2025 Sep 2025 Mar 2026 Equity Capital 10 10 10 11 11 Reserves 392 440 495 524 570 Borrowings 5 4 33 31 35 Other Liabilities 122 173 222 249 291 Total Liabilities 529 626 760 814 907 Fixed Assets 109 179 223 217 213 CWIP 15 6 5 24 60 Investments 107 173 223 246 268 Other Assets 298 268 308 327 366 Total Assets 529 626 760 814 907
WINDLAS cash flows (₹ Cr) Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Cash from Operating Activity 9 61 109 68 105 Cash from Investing Activity -155 -14 -92 -74 -92 Cash from Financing Activity 130 -44 -15 1 -13 Net Cash Flow -15 3 2 -5 0 Free Cash Flow -6 -9 71 16 37 CFO/OP 34% 117% 163% 95% 115%
WINDLAS ratios Metric Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Debtor Days 87 83 79 80 92 Inventory Days 71 84 57 63 40 Days Payable 76 98 121 129 156 Cash Conversion Cycle 81 69 15 14 -24 Working Capital Days 85 71 32 17 14 ROCE 15% 14% 18% 17% 16%